Changes in diet, weight, and serum lipid levels associated with olestra consumption

Ruth E. Patterson, Alan R. Kristal, John C. Peters, Marian L. Neuhouser, Cheryl L. Rock, Lawrence J. Cheskin, Dianne Neumark-Sztainer, Mark D. Thornquist

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Specially manufactured low-fat and non-fat foods have become increasingly available over the past 2 decades and controversy has surrounded the issue of whether these products have beneficial or adverse effects on the health and nutritional status of Americans. Methods: This study examines the association of olestra consumption with changes in dietary intakes of energy, fat, and cholesterol and changes in weight and serum lipid concentrations. Data are from a cohort of 335 participants in the Olestra Post-Marketing Surveillance Study sentinel site in Marion County (Indianapolis, Ind). Diet, weight, and serum lipid levels were assessed before the market release of olestra and 1 year later, after olestra-containing foods were widely available. Olestra intake at the 1-year follow-up was categorized as none, low (>0 to 0.4 g/d), moderate (0.4 to 2.0 g/d), and heavy (>2.0 g/d). Results: Participants in the heavy olestra consumption category significantly reduced dietary intake of percentage of energy from fat (2.7 percentage points, P for trend, .003) and saturated fat (1.1 percentage points, P for trend, .02). Consumers in the highest category of olestra consumption had statistically significantly reduced total serum cholesterol levels of -0.54 mmol/L (-21 mg/dL) compared with -0.14 mmol/L (-5 mg/dL) among olestra nonconsumers (P for trend, .03). Conclusions: These results indicate that introduction of a new fat substitute (olestra) in the US market was associated with healthful changes in dietary fat intake and serum cholesterol concentrations among consumers who chose to consume olestra-containing foods.

Original languageEnglish (US)
Pages (from-to)2600-2604
Number of pages5
JournalArchives of Internal Medicine
Volume160
Issue number17
DOIs
StatePublished - Sep 25 2000

Fingerprint

Diet
Lipids
Weights and Measures
Serum
Fats
Cholesterol
Energy Intake
Food
Fat Substitutes
Sentinel Surveillance
sucrose polyester
Dietary Fats
Marketing
Nutritional Status
Health Status

Cite this

Patterson, R. E., Kristal, A. R., Peters, J. C., Neuhouser, M. L., Rock, C. L., Cheskin, L. J., ... Thornquist, M. D. (2000). Changes in diet, weight, and serum lipid levels associated with olestra consumption. Archives of Internal Medicine, 160(17), 2600-2604. https://doi.org/10.1001/archinte.160.17.2600

Changes in diet, weight, and serum lipid levels associated with olestra consumption. / Patterson, Ruth E.; Kristal, Alan R.; Peters, John C.; Neuhouser, Marian L.; Rock, Cheryl L.; Cheskin, Lawrence J.; Neumark-Sztainer, Dianne; Thornquist, Mark D.

In: Archives of Internal Medicine, Vol. 160, No. 17, 25.09.2000, p. 2600-2604.

Research output: Contribution to journalArticle

Patterson, RE, Kristal, AR, Peters, JC, Neuhouser, ML, Rock, CL, Cheskin, LJ, Neumark-Sztainer, D & Thornquist, MD 2000, 'Changes in diet, weight, and serum lipid levels associated with olestra consumption', Archives of Internal Medicine, vol. 160, no. 17, pp. 2600-2604. https://doi.org/10.1001/archinte.160.17.2600
Patterson RE, Kristal AR, Peters JC, Neuhouser ML, Rock CL, Cheskin LJ et al. Changes in diet, weight, and serum lipid levels associated with olestra consumption. Archives of Internal Medicine. 2000 Sep 25;160(17):2600-2604. https://doi.org/10.1001/archinte.160.17.2600
Patterson, Ruth E. ; Kristal, Alan R. ; Peters, John C. ; Neuhouser, Marian L. ; Rock, Cheryl L. ; Cheskin, Lawrence J. ; Neumark-Sztainer, Dianne ; Thornquist, Mark D. / Changes in diet, weight, and serum lipid levels associated with olestra consumption. In: Archives of Internal Medicine. 2000 ; Vol. 160, No. 17. pp. 2600-2604.
@article{cc4988b6a5fd4362b64ec903b1dd09fb,
title = "Changes in diet, weight, and serum lipid levels associated with olestra consumption",
abstract = "Background: Specially manufactured low-fat and non-fat foods have become increasingly available over the past 2 decades and controversy has surrounded the issue of whether these products have beneficial or adverse effects on the health and nutritional status of Americans. Methods: This study examines the association of olestra consumption with changes in dietary intakes of energy, fat, and cholesterol and changes in weight and serum lipid concentrations. Data are from a cohort of 335 participants in the Olestra Post-Marketing Surveillance Study sentinel site in Marion County (Indianapolis, Ind). Diet, weight, and serum lipid levels were assessed before the market release of olestra and 1 year later, after olestra-containing foods were widely available. Olestra intake at the 1-year follow-up was categorized as none, low (>0 to 0.4 g/d), moderate (0.4 to 2.0 g/d), and heavy (>2.0 g/d). Results: Participants in the heavy olestra consumption category significantly reduced dietary intake of percentage of energy from fat (2.7 percentage points, P for trend, .003) and saturated fat (1.1 percentage points, P for trend, .02). Consumers in the highest category of olestra consumption had statistically significantly reduced total serum cholesterol levels of -0.54 mmol/L (-21 mg/dL) compared with -0.14 mmol/L (-5 mg/dL) among olestra nonconsumers (P for trend, .03). Conclusions: These results indicate that introduction of a new fat substitute (olestra) in the US market was associated with healthful changes in dietary fat intake and serum cholesterol concentrations among consumers who chose to consume olestra-containing foods.",
author = "Patterson, {Ruth E.} and Kristal, {Alan R.} and Peters, {John C.} and Neuhouser, {Marian L.} and Rock, {Cheryl L.} and Cheskin, {Lawrence J.} and Dianne Neumark-Sztainer and Thornquist, {Mark D.}",
year = "2000",
month = "9",
day = "25",
doi = "10.1001/archinte.160.17.2600",
language = "English (US)",
volume = "160",
pages = "2600--2604",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "17",

}

TY - JOUR

T1 - Changes in diet, weight, and serum lipid levels associated with olestra consumption

AU - Patterson, Ruth E.

AU - Kristal, Alan R.

AU - Peters, John C.

AU - Neuhouser, Marian L.

AU - Rock, Cheryl L.

AU - Cheskin, Lawrence J.

AU - Neumark-Sztainer, Dianne

AU - Thornquist, Mark D.

PY - 2000/9/25

Y1 - 2000/9/25

N2 - Background: Specially manufactured low-fat and non-fat foods have become increasingly available over the past 2 decades and controversy has surrounded the issue of whether these products have beneficial or adverse effects on the health and nutritional status of Americans. Methods: This study examines the association of olestra consumption with changes in dietary intakes of energy, fat, and cholesterol and changes in weight and serum lipid concentrations. Data are from a cohort of 335 participants in the Olestra Post-Marketing Surveillance Study sentinel site in Marion County (Indianapolis, Ind). Diet, weight, and serum lipid levels were assessed before the market release of olestra and 1 year later, after olestra-containing foods were widely available. Olestra intake at the 1-year follow-up was categorized as none, low (>0 to 0.4 g/d), moderate (0.4 to 2.0 g/d), and heavy (>2.0 g/d). Results: Participants in the heavy olestra consumption category significantly reduced dietary intake of percentage of energy from fat (2.7 percentage points, P for trend, .003) and saturated fat (1.1 percentage points, P for trend, .02). Consumers in the highest category of olestra consumption had statistically significantly reduced total serum cholesterol levels of -0.54 mmol/L (-21 mg/dL) compared with -0.14 mmol/L (-5 mg/dL) among olestra nonconsumers (P for trend, .03). Conclusions: These results indicate that introduction of a new fat substitute (olestra) in the US market was associated with healthful changes in dietary fat intake and serum cholesterol concentrations among consumers who chose to consume olestra-containing foods.

AB - Background: Specially manufactured low-fat and non-fat foods have become increasingly available over the past 2 decades and controversy has surrounded the issue of whether these products have beneficial or adverse effects on the health and nutritional status of Americans. Methods: This study examines the association of olestra consumption with changes in dietary intakes of energy, fat, and cholesterol and changes in weight and serum lipid concentrations. Data are from a cohort of 335 participants in the Olestra Post-Marketing Surveillance Study sentinel site in Marion County (Indianapolis, Ind). Diet, weight, and serum lipid levels were assessed before the market release of olestra and 1 year later, after olestra-containing foods were widely available. Olestra intake at the 1-year follow-up was categorized as none, low (>0 to 0.4 g/d), moderate (0.4 to 2.0 g/d), and heavy (>2.0 g/d). Results: Participants in the heavy olestra consumption category significantly reduced dietary intake of percentage of energy from fat (2.7 percentage points, P for trend, .003) and saturated fat (1.1 percentage points, P for trend, .02). Consumers in the highest category of olestra consumption had statistically significantly reduced total serum cholesterol levels of -0.54 mmol/L (-21 mg/dL) compared with -0.14 mmol/L (-5 mg/dL) among olestra nonconsumers (P for trend, .03). Conclusions: These results indicate that introduction of a new fat substitute (olestra) in the US market was associated with healthful changes in dietary fat intake and serum cholesterol concentrations among consumers who chose to consume olestra-containing foods.

UR - http://www.scopus.com/inward/record.url?scp=0034715305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034715305&partnerID=8YFLogxK

U2 - 10.1001/archinte.160.17.2600

DO - 10.1001/archinte.160.17.2600

M3 - Article

C2 - 10999973

AN - SCOPUS:0034715305

VL - 160

SP - 2600

EP - 2604

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 17

ER -